SOURCE: Medical Nutrition USA, Inc.

Medical Nutrition USA, Inc.

June 11, 2009 11:30 ET

Medical Nutrition Signs Retail Licensing Deal With DSE

ENGLEWOOD, NJ--(Marketwire - June 11, 2009) - Medical Nutrition USA, Inc. (NASDAQ: MDNU) today announced it signed an exclusive agreement with DSE Healthcare Solutions, LLC to market its Proantinox® product to U.S. retail outlets.

The 10-year Trademark License Agreement gives DSE the right to utilize intellectual property, including trademarks, patents and formulation, relating to Proantinox®, Medical Nutrition's urinary tract cleansing complex, in return for royalty payments based on sales to the retail market. Medical Nutrition will continue to market the product to the institutional market under the UTI-Stat™ brand. Proantinox® (UTI- Stat™) is a liquid urinary tract cleansing complex developed by Medical Nutrition that has been shown to be effective in reducing recurrent urinary tract infections.

"We are pleased to partner with DSE, whose retail offerings include Cystex®, a dual-action urinary tract analgesic that is complementary to Proantinox® and is carried by most major food, drug and mass market retailers. We believe that the co-marketing of Proantinox® with the Cystex® brand will hasten its acceptance and broaden distribution beyond what would have been achieved independently," said Frank A. Newman, Medical Nutrition's Chairman and Chief Executive Officer.

DSE markets leading specialty health products through a number of national and regional retail outlets including Walgreen's, CVS, Rite Aid, Walmart, Target stores, Duane Reade, Safeway, Winn Dixie and Giant Foods.

"Proantinox® is a great product that is well accepted in the institutional market and we are excited about the opportunity to bring it to the retail market," said Moaiz Daya, DSE's Chief Executive Officer. "We think the addition of Proantinox® to the Cystex® line makes for a very powerful two-punch approach to urinary tract infections."

About DSE Healthcare Solutions, LLC

DSE Healthcare Solutions, LLC offers products that provide relief for specialty health concerns. Examples of leading specialty health brands include: #1 ENT doctor recommended Lipo-Flavonoid for ringing in the ears or tinnitus; Certain Dri, the #1 doctor recommended brand for controlling excessive underarm sweating; Cystex, the only over-the-counter urinary pain reliever available with a dual-action formula that eases pain and burning caused by a UTI plus contains an antibacterial to help keep the infection from getting worse while waiting for a doctor's appointment; Albolene® Moisturizing Cleanser, a makeup remover that easily cleanses stubborn mascara and lipstick, yet leaves skin feeling soft, supple and moisturized; Anti Monkey Butt Powder, specially formulated with calamine powder to absorb excess sweat and reduce frictional skin irritation. Additional information is available at

About Medical Nutrition USA

Medical Nutrition USA develops and distributes products for the nutritionally at risk who are under medical supervision. Its products are used primarily in long-term care facilities, hospitals, dialysis clinics and bariatric clinics. The Company's product lines include Pro-Stat®, Fiber-Stat® and UTI-Stat™, as well as private label products. Additional information is available at

This press release contains forward-looking statements that are subject to certain risks and uncertainties. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed. Risks and uncertainties that could cause or contribute to such material difference include, but are not limited to, general economic conditions, changes in customer demand, changes in trends in the nursing home, renal care, health food and bariatric surgery markets, changes in competitive pricing for products, and the impact of our competitors' new product introductions. Our future financial condition and results of operations, as well as any forward-looking statements are subject to change and inherent risk and uncertainties. Other important factors that may cause actual results to differ materially from those expressed in forward-looking statements is contained in the Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year ended January 31, 2009 as filed with the Securities and Exchange Commission on April 24, 2009.

Contact Information

  • Contacts:
    Medical Nutrition USA, Inc.
    Frank J. Kimmerling
    Vice President/CFO
    Email Contact

    Investor Relations
    Adam Friedman
    212.981.2529 x18
    Email Contact